IP Library Granted Patent US 7,214,797
Granted Patent B2
US 7,214,797 · App. 11/254,311 · Granted May 8, 2007

Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,214,797
App. No.
11/254,311
Granted
May 8, 2007
Kind
B2
Abstract

Fluorenecarboxylic acid esters of general formula 1 wherein X − and the groups A, R, R 1 , R 2 , R 3 , R 3′ , R 4 , and R 4′ have the meanings given in the claims and in the specification, processes for the manufacture thereof and the use thereof as medicaments.

Claims (33)

1. A process for preparing a compound according to formula 1,

the process comprising in a first step:

reacting a compound of formula 2

with a compound of formula 3

wherein R′ denotes chlorine or a C 1 –C 4 -alkyloxy group,

to produce an intermediate compound of formula 4

and in a second step

reacting the intermediate compound of formula 4 with a compound of the formula R 2 —X,

wherein

A is a group selected from

R is methyl, ethyl, —CF 3 , or —CHF 2 ;

R 1 and R 2 , which are identical or different, are each C 1 –C 3 -alkyl;

R 3 , R 4 , R 3′ and R 4′ which may be identical or different denote hydrogen, —C 1 –C 4 -alkyl, —C 1 –C 4 -alkyloxy, hydroxy, —CF 3 , —CHF 2 , CN, NO 2 or halogen; and

X − is an anion with a single negative charge.

2. The process according to claim 1 , wherein X − is chloride, bromide, 4-toluenesulfonate, or methane-sulfonate, R is methyl, R 3 , R 4 , R 3′ and R 4′ are hydrogen, and R 1 and R 2 , which are identical or different, are each methyl or ethyl.

3. The process according to claim 1 , wherein X − is chloride, bromide, or methane-sulfonate, R is methyl, R 3 , R 4 , R 3′ and R 4′ are hydrogen, and R 1 and R 2 are methyl.

4. The process according to claim 1 , wherein X is bromide, R is methyl, R 3 , R 4 , R 3′ and R 4′ are hydrogen, and R 1 and R 2 , which are identical or different, are each methyl or ethyl.

5. A compound according to formula 1,

wherein

A is a group selected from

R is methyl, ethyl, —CF 3 , or —CHF 2 ;

R 1 and R 2 , which are identical or different, are each —C 1 –C 3 -alkyl;

R 3 , R 4 , R 3′ and R 4′ which may be identical or different denote hydrogen, —C 1 –C 4 -alkyl, —C 1 –C 4 -alkyloxy, hydroxy, —CF 3 , —CHF 2 , CN, NO 2 or halogen; and

X − is an anion with a single negative charge,

the compound produced by a process comprising:

in a first sten reacting a compound of formula 2

with a compound of formula 3

wherein R′ denotes chlorine or a C 1 –C 4 -alkyloxy group,

to produce an intermediate compound of formula 4

and in a second step reacting the intermediate compound of formula 4 with a compound of the formula R 2 —X to form a comnound of formula 1.

6. The compound according to claim 5 , wherein X − is chloride, bromide, 4-toluenesulfonate, or methane-sulfonate, R 3 , R 4 , R 3′ and R 4′ are hydrogen, R is methyl, and R 1 and R 2 , which are identical or different, are each methyl or ethyl.

7. The compound according to claim 5 , wherein X − is chloride, bromide, or methane-sulfonate, R 3 , R 4 , R 3′ and R 4′ are hydrogen, R is methyl, and R 1 and R 2 are methyl.

8. The compound according to claim 5 , wherein X − is bromide, R 3 , R 4, R 3′ and R 4′ are hydrogen, R is methyl, and R 1 and R 2 , which are identical or different, are each methyl or ethyl.

Assignments (1)
CHANGE OF NAME Recorded Mar 12, 2007
From: BOEHRINGER INGELHEIM PHARMA KG
To: BOEHRINGER INGELHEIM PHARMA GMBH & CO KG
Reel/Frame 018993/0839 →